Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Clin Transl Med ; 11(12): e674, 2021 12.
Article in English | MEDLINE | ID: mdl-34954904

ABSTRACT

BACKGROUND AND PURPOSE: The aim of this study is to decipher the underlying mechanisms of CCAAT/enhancer-binding protein delta (CEBPD)-enhanced glycolysis as well as the biological significance of CEBPD and MYC coamplification in urothelial carcinoma (UC). METHODS: In vitro analyses were conducted to examine the effects of altered CEBPD or MYC expression on UC cells. The in vivo effects of CEBPD overexpression in a high-glucose environment on tumour growth were investigated in xenografted induced diabetic severe combined immunodeficiency/beige mice. Data mining was used to cross-validate the associations between CEBPD and MYC copy number and transcriptional expression, quantitative reverse transcription-polymerase chain reaction, immunohistochemistry, chromogenic in situ hybridization, and in situ hybridization targeting microRNA were performed on 635 UC patient samples and xenograft samples. UC patient survival in relation to diabetes was validated by using the National Health Insurance Research Database. RESULTS: CEBPD and MYC coamplification (29.6%) occurred at a high frequency, MYC expression promoted chromosomal instability, facilitating CEBPD copy number gain and expression. CEBPD promoted glucose uptake and lactate production by upregulating SLC2A1 and HK2, leading to mitochondrial fission, increased extracellular acidification rate and decreased oxygen consumption rate to fuel cell growth. CEBPD upregulated HK2 expression through multiple regulation pathways including MYC stabilization, suppression of FBXW7 transactivation and MYC-independent transcriptional suppression of hsa-miR-429. Clinical and xenografted experiments confirmed the growth advantage of CEBPD in relation to glucose metabolic dysregulation and the significant correlations between the expression of these genes. CONCLUSIONS: We confirmed that CEBPD has an oncogenic role in UC by activating AKT signalling and initiating metabolic reprogramming from mitochondrial oxidative phosphorylation to glycolysis to satisfy glucose addiction. These novel CEBPD- and MYC-centric multilayered positive feedback loops enhance cancer growth that could complement theranostic approaches.


Subject(s)
CCAAT-Enhancer-Binding Protein-delta/drug effects , Genes, myc/drug effects , Urinary Bladder Neoplasms/genetics , Urothelium/physiopathology , Animals , Cell Proliferation/drug effects , Disease Models, Animal , Feedback, Physiological/drug effects , Feedback, Physiological/physiology , Mice , Urothelium/abnormalities , Warburg Effect, Oncologic
2.
J Pathol ; 249(4): 472-484, 2019 12.
Article in English | MEDLINE | ID: mdl-31400222

ABSTRACT

Transforming growth factor-ß (TGFß) has been reported to be dysregulated in malformed ureters. There exists, however, little information on whether altered TGFß levels actually perturb ureter development. We therefore hypothesised that TGFß has functional effects on ureter morphogenesis. Tgfb1, Tgfb2 and Tgfb3 transcripts coding for TGFß ligands, as well as Tgfbr1 and Tgfbr2 coding for TGFß receptors, were detected by quantitative polymerase chain reaction in embryonic mouse ureters collected over a wide range of stages. As assessed by in situ hybridisation and immunohistochemistry, the two receptors were detected in embryonic urothelia. Next, TGFß1 was added to serum-free cultures of embryonic day 15 mouse ureters. These organs contain immature smooth muscle and urothelial layers and their in vivo potential to grow and acquire peristaltic function can be replicated in serum-free organ culture. Such organs therefore constitute a suitable developmental stage with which to define roles of factors that affect ureter growth and functional differentiation. Exogenous TGFß1 inhibited growth of the ureter tube and generated cocoon-like dysmorphogenesis. RNA sequencing suggested that altered levels of transcripts encoding certain fibroblast growth factors (FGFs) followed exposure to TGFß. In serum-free organ culture exogenous FGF10 but not FGF18 abrogated certain dysmorphic effects mediated by exogenous TGFß1. To assess whether an endogenous TGFß axis functions in developing ureters, embryonic day 15 explants were exposed to TGFß receptor chemical blockade; growth of the ureter was enhanced, and aberrant bud-like structures arose from the urothelial tube. The muscle layer was attenuated around these buds, and peristalsis was compromised. To determine whether TGFß effects were limited to one stage, explants of mouse embryonic day 13 ureters, more primitive organs, were exposed to exogenous TGFß1, again generating cocoon-like structures, and to TGFß receptor blockade, again generating ectopic buds. As for the mouse studies, immunostaining of normal embryonic human ureters detected TGFßRI and TGFßRII in urothelia. Collectively, these observations reveal unsuspected regulatory roles for endogenous TGFß in embryonic ureters, fine-tuning morphogenesis and functional differentiation. Our results also support the hypothesis that the TGFß up-regulation reported in ureter malformations impacts on pathobiology. Further experiments are needed to unravel the intracellular signalling mechanisms involved in these dysmorphic responses. © 2019 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.


Subject(s)
Morphogenesis , Transforming Growth Factor beta/metabolism , Ureter/abnormalities , Ureter/metabolism , Urogenital Abnormalities/metabolism , Urothelium/abnormalities , Urothelium/metabolism , Animals , Cell Differentiation , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/metabolism , Gene Expression Regulation, Developmental , Gestational Age , Humans , Mice , Organ Culture Techniques , Receptors, Transforming Growth Factor beta/genetics , Receptors, Transforming Growth Factor beta/metabolism , Signal Transduction , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/pharmacology , Ureter/drug effects , Urogenital Abnormalities/genetics , Urothelium/drug effects
3.
Pediatr Nephrol ; 34(8): 1325-1335, 2019 08.
Article in English | MEDLINE | ID: mdl-29961928

ABSTRACT

Hepatocyte nuclear factor-1ß (HNF-1ß) is an essential transcription factor that regulates the development and function of epithelia in the kidney, liver, pancreas, and genitourinary tract. Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis. In the embryonic kidney, HNF-1ß is required for ureteric bud branching, initiation of nephrogenesis, and nephron segmentation. Ablation of mouse Hnf1b in nephron progenitors causes defective tubulogenesis, whereas later inactivation in elongating tubules leads to cyst formation due to downregulation of cystic disease genes, including Umod, Pkhd1, and Pkd2. In the adult kidney, HNF-1ß controls the expression of genes required for intrarenal metabolism and solute transport by tubular epithelial cells. Tubular abnormalities observed in HNF-1ß nephropathy include hyperuricemia with or without gout, hypokalemia, hypomagnesemia, and polyuria. Recent studies have identified novel post-transcriptional and post-translational regulatory mechanisms that control HNF-1ß expression and activity, including the miRNA cluster miR17 ∼ 92 and the interacting proteins PCBD1 and zyxin. Further understanding of the molecular mechanisms upstream and downstream of HNF-1ß may lead to the development of new therapeutic approaches in cystic kidney disease and other HNF1B-related renal diseases.


Subject(s)
Gene Expression Regulation, Developmental , Hepatocyte Nuclear Factor 1-beta/metabolism , Kidney Diseases, Cystic/genetics , Kidney Tubules/abnormalities , Urothelium/abnormalities , Down-Regulation , Hepatocyte Nuclear Factor 1-beta/genetics , Humans , Hydro-Lyases/metabolism , Kidney Diseases, Cystic/blood , Kidney Diseases, Cystic/pathology , Kidney Diseases, Cystic/urine , Kidney Tubules/pathology , MicroRNAs/metabolism , Mutation , RNA, Long Noncoding , Receptors, Cell Surface/genetics , TRPP Cation Channels/genetics , Uromodulin/genetics , Urothelium/pathology , Zyxin/metabolism
4.
Kidney Int ; 89(3): 612-24, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26880456

ABSTRACT

Proper development and maintenance of urothelium is critical to its function. Uroplakins are expressed in developing and mature urothelium where they establish plaques associated with the permeability barrier. Their precise functional role in development and disease is unknown. Here, we disrupted Upk1b in vivo where its loss resulted in urothelial plaque disruption in the bladder and kidney. Upk1b(RFP/RFP) bladder urothelium appeared dysplastic with expansion of the progenitor cell markers, Krt14 and Krt5, increased Shh expression, and loss of terminal differentiation markers Krt20 and uroplakins. Upk1b(RFP/RFP) renal urothelium became stratified with altered cellular composition. Upk1b(RFP/RFP) mice developed age-dependent progressive hydronephrosis. Interestingly, 16% of Upk1b(RFP/RFP) mice possessed unilateral duplex kidneys. Our study expands the role of uroplakins, mechanistically links plaque formation to urinary tract development and function, and provides a tantalizing connection between congenital anomalies of the kidney and urinary tract along with functional deficits observed in a variety of urinary tract diseases. Thus, kidney and bladder urothelium are regionally distinct and remain highly plastic, capable of expansion through tissue-specific progenitor populations. Furthermore, Upk1b plays a previously unknown role in early kidney development representing a novel genetic target for congenital anomalies of the kidney and urinary tract.


Subject(s)
Cell Differentiation , Kidney/metabolism , Tetraspanins/metabolism , Urinary Bladder/metabolism , Urothelium/metabolism , Animals , Cell Proliferation , Gene Expression Regulation, Developmental , Genotype , Homeostasis , Hydronephrosis/genetics , Hydronephrosis/metabolism , Kidney/abnormalities , Kidney/ultrastructure , Mice, Knockout , Phenotype , Signal Transduction , Tetraspanins/deficiency , Tetraspanins/genetics , Urinary Bladder/abnormalities , Urinary Bladder/ultrastructure , Urogenital Abnormalities/genetics , Urogenital Abnormalities/metabolism , Uroplakin Ib , Urothelium/abnormalities , Urothelium/ultrastructure , Vesico-Ureteral Reflux/genetics , Vesico-Ureteral Reflux/metabolism
5.
Int J Clin Exp Pathol ; 8(11): 15422-5, 2015.
Article in English | MEDLINE | ID: mdl-26823906

ABSTRACT

Urothelial carcinoma (UC) originated from renal pelvis is the common tumor of the urinary system, however, neoplasia of the renal pelvis in duplex kidneys is extremely rare, especially in the complete renal and ureteral duplex cases. We present the first case of renal pelvis UC of the upper moiety in a complete right renal duplex. This male patient has bilateral complete renal and ureteral duplex. To the best of our knowledge, this is the first reported case of renal pelvis UC in a complete renal duplex system. After this experience we feel that the diagnosis of renal pelvis UC in duplex kidneys is not so easy, and once the diagnosis is determined, the whole renal duplex units and bladder cuff or ectopic orifice should be excised radically.


Subject(s)
Carcinoma/pathology , Kidney Neoplasms/pathology , Kidney Pelvis/abnormalities , Ureter/abnormalities , Urothelium/abnormalities , Aged , Biopsy , Carcinoma/surgery , Chemotherapy, Adjuvant , Humans , Kidney Neoplasms/surgery , Kidney Pelvis/surgery , Male , Nephrectomy , Predictive Value of Tests , Tomography, X-Ray Computed , Treatment Outcome , Ureter/surgery , Urothelium/surgery
7.
Mech Dev ; 130(11-12): 567-76, 2013.
Article in English | MEDLINE | ID: mdl-23933588

ABSTRACT

Reproductive tract abnormalities and male infertility have higher incidence in ADPKD patients than in general populations. In this work, we reveal that Pkd1, whose mutations account for 85% of ADPKD cases, is essential for male reproductive tract development. Disruption of Pkd1 caused multiple organ defects in the murine male reproductive tract. The earliest visible defect in the Pkd1(-/-) reproductive tract was cystic dilation of the efferent ducts, which are derivatives of the mesonephric tubules. Epididymis development was delayed or arrested in the Pkd1(-/-) mice. No sign of epithelial coiling was seen in the null mutants. Disruption of Pkd1 in epithelium alone using the Pax2-cre mice was sufficient to cause efferent duct dilation and coiling defect in the epididymis, suggesting that Pkd1 is critical for epithelium development and maintenance in male reproductive tract. In-depth analysis showed that Pkd1 is required to maintain tubulin cytoskeleton and important for Tgf-ß/Bmp signal transduction in epithelium of male reproductive tract. Altogether, our results for the first time provide direct evidence for developmental roles of Pkd1 in the male reproductive tract and provide new insights in reproductive tract abnormalities and infertility in ADPKD patients.


Subject(s)
Body Patterning/genetics , Epididymis/metabolism , Infertility, Male/genetics , TRPP Cation Channels/genetics , Urothelium/metabolism , Wolffian Ducts/metabolism , Animals , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Embryo, Mammalian , Epididymis/abnormalities , Gene Expression Regulation, Developmental , Humans , Infertility, Male/embryology , Infertility, Male/metabolism , Infertility, Male/pathology , Integrases/genetics , Integrases/metabolism , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , PAX2 Transcription Factor/genetics , PAX2 Transcription Factor/metabolism , Polycystic Kidney, Autosomal Dominant/genetics , Polycystic Kidney, Autosomal Dominant/metabolism , Polycystic Kidney, Autosomal Dominant/pathology , Signal Transduction , TRPP Cation Channels/deficiency , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Tubulin/metabolism , Tubulin/ultrastructure , Urothelium/abnormalities , Wolffian Ducts/abnormalities
8.
Am J Pathol ; 178(3): 1350-60, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21356385

ABSTRACT

The TP63 gene, a member of the TP53 tumor suppressor gene family, can be expressed as at least six isoforms due to alternative promoter use and alternative splicing. The lack of p63 isoform-specific antibodies has limited the analysis of the biological significance of p63. We report a novel set of well-defined antibodies to examine p63 isoforms in mouse and human urothelium during embryogenesis and tumor progression, respectively. We provide evidence that basal and intermediate urothelial cells express p63 isoforms, with the TAp63 variant the first to be detected during development, whereas umbrella cells are characterized by a p63-negative phenotype. Notably, we report that p63-null mice develop a bladder with an abnormal urothelium, constituted by a single layer of cells that express uroplakin II and low molecular weight cytokeratins, consistent with an umbrella cell phenotype. Finally, analysis of 202 human bladder carcinomas revealed a new categorization of invasive tumors into basal-like (positive for ΔNp63 and high molecular weight cytokeratins and negative for low molecular weight cytokeratins) versus luminal-like (negative for ΔNp63 and high molecular weight cytokeratins and positive for low molecular weight cytokeratins) phenotypes, with ΔNp63 expression associated with an aggressive clinical course and poor prognosis. This study highlights the relevance of p63 isoforms in both urothelial development and bladder carcinoma progression, with ΔNp63 acting as an oncogene in certain invasive bladder tumors.


Subject(s)
Disease Progression , Phosphoproteins/metabolism , Trans-Activators/metabolism , Tumor Suppressor Proteins/metabolism , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/pathology , Urothelium/embryology , Urothelium/metabolism , Animals , Antibody Specificity/immunology , Cell Line, Tumor , Humans , Mice , Models, Biological , Mutant Proteins/metabolism , Neoplasm Invasiveness , Phenotype , Phosphoproteins/deficiency , Protein Isoforms/metabolism , Reproducibility of Results , Trans-Activators/deficiency , Transcription Factors , Treatment Outcome , Tumor Suppressor Protein p53/metabolism , Urothelium/abnormalities , Urothelium/pathology
9.
Pediatr Dev Pathol ; 9(1): 72-4, 2006.
Article in English | MEDLINE | ID: mdl-16808629

ABSTRACT

Ureteropelvic junction obstruction (UPJO) constitutes a significant cause of morbidity in children and exists in a wide range of severity and clinical manifestations. The cause of UPJO remains largely unknown except for a small group, in which crossing vessels have been considered etiological. Herein we describe a unique case in which intraluminal occlusion was the result of mucosal malformation, characterized by invaginated and branching urothelial epithelium present in the lamina propria. We believe that the present case is the first such description of this type of alteration.


Subject(s)
Kidney Pelvis/pathology , Ureter/pathology , Ureteral Obstruction/etiology , Urothelium/abnormalities , Adult , Biomarkers/metabolism , Female , Humans , Kidney Pelvis/metabolism , Ureter/metabolism , Ureteral Obstruction/metabolism , Urothelium/metabolism
10.
J Clin Invest ; 116(3): 635-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16511599

ABSTRACT

Radial patterning in the urinary tract and gut depends on reciprocal signaling between epithelial cells, which form mucosa, and mesenchyme, which forms smooth muscle and connective tissue. These interactions depend on sonic hedgehog (Shh), which is secreted by epithelial cells and induces expression of bone morphogenetic protein 4 (Bmp4), a signaling molecule required for differentiation of smooth muscle progenitors. Patterning of the specialized mucosa lining the anterior-posterior (A-P) axis may be controlled independently by regionally expressed mesenchymal transcription factors. A study by Airik et al. in this issue of the JCI reveals that T-box 18 (Tbx18), a transcription factor selectively expressed in ureteral mesenchyme, regulates smooth muscle differentiation by maintaining Shh1 responsiveness in mesenchymal progenitors (see the related article beginning on page 663). Deletion of Tbx18 resulted in defective urothelial differentiation at the level of the ureter, suggesting that Tbx18 acts via mesenchyme as an important regulator of A-P patterning in the urinary tract.


Subject(s)
Body Patterning/physiology , Cell Differentiation/physiology , Gastrointestinal Tract/cytology , Gastrointestinal Tract/physiology , Urinary Tract Physiological Phenomena , Urothelium/cytology , Urothelium/physiology , Animals , Gastrointestinal Tract/abnormalities , Gastrointestinal Tract/embryology , Mice , Urothelium/abnormalities , Urothelium/embryology
11.
Differentiation ; 73(4): 121-33, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15901280

ABSTRACT

Urinary bladder malfunction and disorders are caused by congenital diseases, trauma, inflammation, radiation, and nerve injuries. Loss of normal bladder function results in urinary tract infection, incontinence, renal failure, and end-stage renal dysfunction. In severe cases, bladder augmentation is required using segments of the gastrointestinal tract. However, use of gastrointestinal mucosa can result in complications such as electrolyte imbalance, stone formation, urinary tract infection, mucous production, and malignancy. Recent tissue engineering techniques use acellular grafts, cultured cells combined with biodegradable scaffolds, and cell sheets. These techniques are not all currently applicable for human bladder reconstruction. However, new avenues for bladder reconstruction maybe facilitated by a better understanding of urogenital development, the cellular and molecular biology of urothelium, and cell-cell interactions, which modulate tissue repair, homeostasis, and disease progression.


Subject(s)
Regeneration , Tissue Engineering , Urinary Bladder/embryology , Urinary Bladder/physiology , Animals , Cell Differentiation , Humans , Kidney/embryology , Tissue Transplantation , Urinary Bladder/cytology , Urothelium/abnormalities , Urothelium/embryology , Urothelium/metabolism
12.
J Cell Biol ; 161(1): 119-29, 2003 Apr 14.
Article in English | MEDLINE | ID: mdl-12682085

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) and hepatocyte growth factor (HGF) are multifunctional signaling molecules in embryogenesis. HGF binds to and activates Met receptor tyrosine kinase. The signaling receptor complex for GDNF typically includes both GDNF family receptor alpha1 (GFRalpha1) and Ret receptor tyrosine kinase. GDNF can also signal independently of Ret via GFRalpha1, although the mechanism has remained unclear. We now show that GDNF partially restores ureteric branching morphogenesis in ret-deficient mice with severe renal hypodysplasia. The mechanism of Ret-independent effect of GDNF was therefore studied by the MDCK cell model. In MDCK cells expressing GFRalpha1 but no Ret, GDNF stimulates branching but not chemotactic migration, whereas both branching and chemotaxis are promoted by GDNF in the cells coexpressing Ret and GFRalpha1, mimicking HGF/Met responses in wild-type MDCK cells. Indeed, GDNF induces Met phosphorylation in several ret-deficient/GFRalpha1-positive and GFRalpha1/Ret-coexpressing cell lines. However, GDNF does not immunoprecipite Met, making a direct interaction between GDNF and Met highly improbable. Met activation is mediated by Src family kinases. The GDNF-induced branching of MDCK cells requires Src activation, whereas the HGF-induced branching does not. Our data show a mechanism for the GDNF-induced branching morphogenesis in non-Ret signaling.


Subject(s)
Drosophila Proteins , Kidney/abnormalities , Nerve Growth Factors/metabolism , Proto-Oncogene Proteins c-met/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Ureter/abnormalities , Urothelium/abnormalities , src-Family Kinases/metabolism , Animals , Body Patterning/drug effects , Body Patterning/genetics , Cell Differentiation/drug effects , Cell Differentiation/genetics , Chemotaxis/drug effects , Chemotaxis/genetics , Dogs , Glial Cell Line-Derived Neurotrophic Factor , Glial Cell Line-Derived Neurotrophic Factor Receptors , Hepatocyte Growth Factor/metabolism , Humans , Kidney/cytology , Kidney/metabolism , Phosphorylation/drug effects , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/deficiency , Receptor Protein-Tyrosine Kinases/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , Transfection , Tumor Cells, Cultured , Ureter/cytology , Ureter/metabolism , Urothelium/drug effects , Urothelium/metabolism
13.
Semin Diagn Pathol ; 14(2): 133-46, 1997 May.
Article in English | MEDLINE | ID: mdl-9179974

ABSTRACT

Selected tumor-like lesions of the urinary bladder and urethra, particularly those that have been the subject of recent attention in the literature, are reviewed. Within the category of epithelial abnormalities, it has recently been appreciated that cystitis glandularis of the intestinal type is occasionally associated with prominent mucin extravasation into the stroma, a finding that should not lead to the misdiagnosis of adenocarcinoma. Additionally, the problems that nephrogenic adenoma may cause have been the subject of recent study, and a detailed microscopic analysis of this lesion has shed light on the relative frequency of its common, and uncommon, features. Within the category of tumor-like lesions of the bladder, the inflammatory pseudotumor has been the subject of much interest as have müllerian lesions. It has recently been appreciated that endosalpingiosis is rarely seen at this site, usually in association with endocervicosis or endometriosis, leading to the suggested usage of the designation "müllerianosis." Selected other tumor-like lesions of the urinary bladder and urethra are also reviewed, including the problems nephrogenic adenoma may cause when it involves the prostatic urethra in men or a urethral diverticulum in females as well as the peculiar stromal cells that have recently been described within some urethral caruncles.


Subject(s)
Urethral Diseases/pathology , Urinary Bladder Diseases/pathology , Diagnosis, Differential , Humans , Hyperplasia , Male , Urethra/abnormalities , Urethritis/pathology , Urinary Bladder/abnormalities , Urinary Bladder/pathology , Urothelium/abnormalities , Urothelium/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...